Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting

Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting

Abstract Background In a recent post hoc analysis of multinational clinical trial data, dupilumab treatment for patients with moderate or severe atopic dermatitis (AD) reduced all‐cause and AD‐related hospitalisations. Objectives We studied the impact of dupilumab on health care resource utilisation...

Full description

Bibliographic Details
Main Authors: Ken Igawa, Hiroyuki Fujita, Yuki Tajima, Robert Lubwama, Moataz Daoud, Zhixiao Wang, Kazuhiko Arima
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:JEADV Clinical Practice
Subjects:
atopic dermatitis
dupilumab
health care resource utilisation
hospitalisations
Japan
Online Access:https://doi.org/10.1002/jvc2.151

Internet

https://doi.org/10.1002/jvc2.151

Similar Items